Westlake Chemical Partners (WLKP) Common Equity (2016 - 2026)
Westlake Chemical Partners filings provide 13 years of Common Equity readings, the most recent being $802.4 million for Q4 2025.
- On a quarterly basis, Common Equity rose 190.57% to $802.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $802.4 million, a 190.57% increase, with the full-year FY2025 number at $802.4 million, up 190.57% from a year prior.
- Common Equity hit $802.4 million in Q4 2025 for Westlake Chemical Partners, down from $813.3 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $976.2 million in Q1 2022 to a low of $276.1 million in Q4 2024.
- Median Common Equity over the past 5 years was $864.6 million (2023), compared with a mean of $853.3 million.
- Biggest five-year swings in Common Equity: crashed 67.75% in 2024 and later soared 190.57% in 2025.
- Westlake Chemical Partners' Common Equity stood at $972.7 million in 2021, then dropped by 7.09% to $903.7 million in 2022, then decreased by 5.25% to $856.2 million in 2023, then tumbled by 67.75% to $276.1 million in 2024, then soared by 190.57% to $802.4 million in 2025.
- The last three reported values for Common Equity were $802.4 million (Q4 2025), $813.3 million (Q3 2025), and $831.2 million (Q2 2025) per Business Quant data.